Tianjin Medical Journal ›› 2020, Vol. 48 ›› Issue (4): 327-332.doi: 10.11958/20193666

Previous Articles     Next Articles

Consensus on surgical treatment of myasthenia gravis of the Jing-Jin-Ji experts #br#

Myasthenia Gravis Union of Jing-Jin-Ji   

  1. Tianjin General Hospital
  • Received:2019-12-05 Revised:2019-12-31 Published:2020-04-15 Online:2020-06-23

Abstract: Myasthenia gravis (MG) is an autoimmune disease with dystransmission at the neuromuscular junction
(NMJ), which is mediated by acetylcholine receptor antibody, dependent on cellular immunity and participated by
complement. MG is closely related to thymic diseases, so in addition to the medical treatment, thymectomy is an important
way to treat MG. Based on the latest literature at home and abroad, and the experience of more than ten experts in Beijing, Tianjin and Hebei, this paper has written an expert consensus on antibody typing, preoperative examination, surgical indications, surgical methods, postoperative treatment and follow-up of MG, hoping to guide the surgical treatment of MG.

Key words: myasthenia gravis, thymus, surgical treatment

CLC Number: